Head impulses are a routine clinical test of semicircular canal function. At the bedside, they are used to detect malfunctioning of the horizontal semicircular canals. So far, 3-D-search-coil recording is required to reliably test anterior and posterior canal function and to determine the gain of the vestibulo-ocular reflex (VOR). Search-coil recording cannot be done at the bedside. Here we tested whether video-oculography (VOG) is suitable to assess VOR gain for individual canals at the bedside. We recorded head impulses in healthy subjects using a mobile high-frame-rate, head-mounted VOG-device and compared the results with those obtained with standard search-coil recording. Our preliminary results indicate that high-frame-rate VOG is a promising tool to measure and quantify individual semicircular canal function not only at the bedside.
Objective To evaluate the validity of 2D video-oculography (VOG) compared with scleral search coils for horizontal AVOR gain estimation in older individuals. Study Design Cross-sectional validation study. Setting Tertiary care academic medical center. Patients Six individuals age 70 and older. Interventions Simultaneous eye movement recording with scleral search coil (over right eye) and EyeSeeCam VOG camera (over left eye) during horizontal head impulses. Main Outcome Measures Best estimate search coil and VOG horizontal AVOR gain, presence of compensatory saccades using both eye movement recording techniques. Results We observed a significant correlation between search coil and VOG best estimate horizontal AVOR gain (r = 0.86, p = 0.0002). We evaluated individual head impulses and found that the shapes of the head movement and eye movement traces from the coil and VOG systems were similar. Specific features of eye movements seen in older individuals, including overt and covert corrective saccades and anticompensatory eye movements, were captured by both the search coil and VOG systems. Conclusion These data suggest that VOG is a reasonable proxy for search coil eye movement recording in older subjects to estimate VOR gain and the approximate timing of corrective eye movements. VOG offers advantages over the conventional search coil method; it is portable and easy to use, allowing for quantitative VOR estimation in diverse settings such as a routine office-based practice, at the bedside, and potentially in larger scale population analyses.
When shifting gaze to foveate a new target, humans mostly choose a unique set of eye and head movements from an infinite number of possible combinations. This stereotypy suggests that a general principle governs the movement choice. Here, we show that minimizing the impact of uncertainty, i.e., noise affecting motor performance, can account for the choice of combined eye-head movements. This optimization criterion predicts all major features of natural eye-head movements-including the part where gaze is already on target and the eye counter-rotates-such as movement durations, relative eye-head contributions, velocity profiles, and the dependency of gaze shifts on initial eye position. As a critical test of this principle, we show that it also correctly predicts changes in eye and head movement imposed by an experimental increase in the head moment of inertia. This suggests that minimizing the impact of noise is a simple and powerful principle that explains the choice of a unique set of movement profiles and segment coordination in goal-directed action.
Objective: Uni- or bilateral vestibular hypofunction (VH) impairs balance and mobility, and may specifically lead to injury from falls and to disability. The extent of this problem in the general population is still unknown and most likely to be underestimated. Objective of this study was to determine the prevalence, determinants, and consequences of VH in the general population.Methods: Data originates from the cross-sectional second follow-up (FF4) in 2013/14 of the KORA (Cooperative Health Research in the Region of Augsburg)-S4 study (1999–2001) from Southern Germany. This was a random sample of the target population consisting of all residents of the region aged 25–74 years in 1999. We included all participants who reported moderate or severe vertigo or dizziness during the last 12 months and a random sub-sample of participants representative for the general population without vertigo or dizziness during the last 12 months were tested. VH was assessed with the Video-Head Impulse Test (vHIT). Trained examiners applied high-acceleration, small-amplitude passive head rotations (“head impulses”) to the left and right in the plane of the horizontal semicircular canals while participants fixated a target straight ahead. During head impulses, head movements were measured with inertial sensors, eye movements with video-oculography (EyeSeeCam vHIT).Results: A total of 2,279 participants were included (mean age 60.8 years, 51.6% female), 570 (25.0%) with moderate or severe vertigo or dizziness during the last 12 months. Of these, 450 were assessed with vHIT where 26 (5.8%) had unilateral VH, and 16 (3.6%) had bilateral VH. Likewise, 190 asymptomatic participants were tested. Of these 5 (2.6%) had unilateral VH, and 2 (1.1%) had bilateral VH. Prevalence of uni- or bilateral VH among tested symptomatic participants was 2.4% in those < 48 years, and 32.1% in individuals aged 79 and over. Age-adjusted prevalence was 6.7% (95% CI 4.8%; 8.6%). VH was associated with worse health, falls, hearing loss, hearing impairment, and ear pressure.Conclusion: VH may affect between 53 and 95 million adults in Europe and the US. While not all affected persons will experience the full spectrum of symptoms and consequences, adequate diagnostic and therapeutic measures should become standard of care to decrease the burden of disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.